XML 142 R124.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information - Schedules of Segment Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting Information [Line Items]      
Net revenue $ 1,992,523 $ 1,626,373 $ 1,662,991
Cost of goods sold 1,329,551 1,147,214 938,773
Cost of goods sold impairment charges 34,579 126,162 7,815
Gross profit 628,393 352,997 716,403
Selling, general and administrative 326,727 289,598 227,846
Research and development 179,930 188,049 194,190
In-process research and development impairment charges 2,680 46,619 39,259
Acquisition, transaction-related and integration expenses 8,988 16,388 221,818
Restructuring and other charges 2,398 34,345 56,413
Charges (gains) related to legal matters, net 5,860 12,442 (19,711)
Intellectual property legal development expenses 10,655 14,238 16,261
Operating income (loss) 91,155 (248,682) (19,673)
Generics      
Segment Reporting Information [Line Items]      
Net revenue 1,343,210 1,308,843 1,439,031
Cost of goods sold   5,000  
AvKARE      
Segment Reporting Information [Line Items]      
Net revenue 293,746 0 0
Operating Segments      
Segment Reporting Information [Line Items]      
Acquisition, transaction-related and integration expenses   8,346  
Intellectual property legal development expenses 8 1,045  
Operating Segments | Generics      
Segment Reporting Information [Line Items]      
Net revenue 1,343,210 1,308,843 1,439,031
Cost of goods sold 894,422 984,782 835,181
Cost of goods sold impairment charges 34,579 119,145 7,815
Gross profit 414,209 204,916 596,035
Selling, general and administrative 56,134 68,883 68,426
Research and development 150,068 172,196 183,412
In-process research and development impairment charges 2,680 46,619 39,259
Acquisition, transaction-related and integration expenses 328 4,633 114,622
Restructuring and other charges (614) 20,101 33,943
Charges (gains) related to legal matters, net 5,610 12,442 (22,300)
Intellectual property legal development expenses 10,647 13,193 15,772
Operating income (loss) 189,356 (133,151) 162,901
Operating Segments | Specialty      
Segment Reporting Information [Line Items]      
Net revenue 355,567 317,530 223,960
Cost of goods sold 192,910 162,432 103,592
Cost of goods sold impairment charges 0 7,017 0
Gross profit 162,657 148,081 120,368
Selling, general and administrative 75,917 79,665 49,465
Research and development 29,862 15,853 10,778
In-process research and development impairment charges 0 0 0
Acquisition, transaction-related and integration expenses 85   0
Restructuring and other charges 0 391 4,076
Charges (gains) related to legal matters, net 250 0 0
Intellectual property legal development expenses     489
Operating income (loss) 56,535 42,781 55,560
Operating Segments | AvKARE      
Segment Reporting Information [Line Items]      
Net revenue 293,746    
Cost of goods sold 242,219    
Cost of goods sold impairment charges 0    
Gross profit 51,527    
Selling, general and administrative 58,544    
Research and development 0    
In-process research and development impairment charges 0    
Acquisition, transaction-related and integration expenses 641    
Restructuring and other charges 0    
Charges (gains) related to legal matters, net 0    
Intellectual property legal development expenses 0    
Operating income (loss) (7,658)    
Corporate and Other      
Segment Reporting Information [Line Items]      
Net revenue 0 0 0
Cost of goods sold 0 0 0
Cost of goods sold impairment charges 0 0 0
Gross profit 0 0 0
Selling, general and administrative 136,132 141,050 109,955
Research and development 0 0 0
In-process research and development impairment charges 0 0 0
Acquisition, transaction-related and integration expenses 7,934 3,409 107,196
Restructuring and other charges 3,012 13,853 18,394
Charges (gains) related to legal matters, net 0 0 2,589
Intellectual property legal development expenses 0 0 0
Operating income (loss) $ (147,078) $ (158,312) $ (238,134)